Is PSNL Worth Buying in 2026?

Personalis, Inc. Common Stock

STOCK SERVICES-MEDICAL LABORATORIES Updated 2026-05-24

Here’s whether Personalis, Inc. Common Stock (PSNL) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +83.3%; rising volume confirms the move (1.19x 30d avg). Concerns: 50-day MA is falling (-3.95% over 10 days); RSI 78 — overbought, elevated pullback risk. Currently 26.4% off its 52-week high. Score: +3/7.

Ready to act on this? 📈 Trade on Webull

PSNL is in a confirmed uptrend, trading above both its 50-day ($6.53) and 200-day ($7.55) moving averages. With an RSI of 78.4, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +83.3% compares to +27.9% for SPY (beat the market by 55.5%). The current 26.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $18,333 today
vs. S&P 500 (SPY) — same period beat market by 55.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($7.55)
Above 50-day MA ($6.53)
!RSI(14) neutral zone (30–70) — currently 78.4
Positive return (+83.3%)
!Within 10% of period high (−26.4%)
Period Range $8.47
$3.84 $11.50
RSI (14) 78.4
0 · OversoldOverbought · 100

Key Metrics

Price$8.47
Period Return+83.3%
Period High$11.50
Period Low$3.84
Drawdown−26.4%
MA-50$6.53
MA-200$7.55
RSI (14)78.4
Avg Volume (30d)2.3M
vs. SPYbeat by 55.5%
Return Rank#273 of 1236

Trade PSNL

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers